Cargando…
Correction to: Vitiligo and tumor response in a patient with amelanotic melanoma undergoing nivolumab treatment
Autores principales: | Furune, Satoshi, Kondo, Chiaki, Takano, Yuko, Shimokata, Tomoya, Sugishita, Mihoko, Mitsuma, Ayako, Maeda, Osamu, Ando, Yuichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787004/ https://www.ncbi.nlm.nih.gov/pubmed/35129544 http://dx.doi.org/10.1007/s13691-021-00517-8 |
Ejemplares similares
-
Vitiligo and tumor response in a patient with amelanotic melanoma undergoing nivolumab treatment
por: Furune, Satoshi, et al.
Publicado: (2021) -
Drug-induced thrombocytopenia associated with trastuzumab in a patient with HER2-positive recurrent gastric cancer
por: Takano, Yuko, et al.
Publicado: (2021) -
Chemotherapy for biliary tract cancer: real-world experience in a single institute
por: Maeda, Osamu, et al.
Publicado: (2020) -
Amelanotic Acral Melanoma Associated with KIT Mutation and Vitiligo
por: Kim, Young Jee, et al.
Publicado: (2015) -
EXTRAVASATION OF PEGYLATED-LIPOSOMAL DOXORUBICIN: FAVORABLE OUTCOME AFTER IMMEDIATE SUBCUTANEOUS ADMINISTRATION OF CORTICOSTEROIDS
por: MITSUMA, AYAKO, et al.
Publicado: (2012)